Circuit-breakers: Optical technologies for probing neural signals and systems

Nature Reviews Neuroscience

Volumn 8, Issue 8, 2007, Pages 577-581

  Zhang, Feng ^a   Aravanis, Alexander M ^a   Adamantidis, Antoine ^b   De Lecea, Luis ^b   Deisseroth, Karl ^a  

^a Stanford University ^*  (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HALORHODOPSIN; OPSIN; RHODOPSIN;

BEHAVIOR; BRAIN NERVE CELL; CELL SPECIFICITY; CELL TYPE; CHRONIC PAIN; DEPRESSION; ENVIRONMENTAL FACTOR; EPIGENETICS; EPILEPSY; HUMAN; MEDICAL TECHNOLOGIST; MEDICAL TECHNOLOGY; MOLECULAR PROBE; NERVE CELL NETWORK; NERVOUS SYSTEM; NEUROMODULATION; NEUROPSYCHIATRY; NONHUMAN; OBSESSIVE COMPULSIVE DISORDER; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; GENE TRANSFER TECHNIQUES; HUMANS; NEURAL PATHWAYS; NEUROPHYSIOLOGY; OPTICS; PHOTIC STIMULATION; PHOTOTRANSDUCTION; RHODOPSINS, MICROBIAL; SYNAPTIC TRANSMISSION;

ANIMALIA; MAMMALIA;

EID: 34547117635     PISSN: 1471003X     EISSN: 14710048     Source Type: Journal    
DOI: 10.1038/nrn2192     Document Type: Review

References (52)

1. Beal, M. F. Experimental models of Parkinson's disease. Nature Rev. Neurosci. 2, 325-334 (2001).
2. Santarelli, L. et al. Requirement of hippocampal neurogenesis for the behavioural effects of antidepressants. Science 301, 805-809 (2003).
3. Lewis, D. A. GABAergic local circuit neurons and prefrontal cortical dysfunction in schizophrenia. Brain Res. Brain Res. Rev. 31, 270-276 (2000).
4. Hashimoto, T., et al. Gene expression deficits in a subclass of GABA neurons in the prefrontal cortex of subjects with schizophrenia. J. Neurosci. 23, 6315-6326 (2003).
5. Volk, D., Austin, M., Pierri, J., Sampson, A. & Lewis, D. GABA transporter-1 mRNA in the prefrontal cortex in schizophrenia: decreased expression in a subset of neurons. Am. J. Psychiatry 158, 256-265 (2001).
6. Zhang, F. et al. Multimodal fast optical interrogation of neural circuitry. Nature 446, 633-639 (2007).
7. Lima, S. Q. & Miesenbock, G. Remote control of behaviour through genetically targeted photostimulation of neurons. Cell 121, 141-152 (2005).
8. Karpova, A.Y., Tervo, D.G., Gray, N.W. & Svoboda, K. Rapid and reversible chemical inactivation of synaptic transmission in genetically targeted neurons. Neuron 48, 727-735 (2005).
9. Tan, E.M., et al. Selective and quickly reversible inactivation of mammalian neurons in vivo using the Drosophila allatostatin receptor. Neuron 51, 157-170 (2006).
10. Lerchner, W., et al. Reversible silencing of neuronal excitability in behaving mice by a genetically targeted, ivermectin-gated Cl- channel. Neuron 54, 35-49 (2007).
11. Szobota, S. et al. Remote control of neuronal activity with a light-gated glutamate receptor. Neuron 54, 535-545 (2007).
12. Boyden, E. S., Zhang, F., Bamberg, E., Nagel, G. & Deisseroth, K. Millisecond-timescale, genetically targeted optical control of neural activity. Nature Neurosci. 8, 1263-1268 (2005).
13. Zhang, F., Wang, L. P., Boyden, E. S. & Deisseroth, K. Channelrhodopsin-2 and optical control of excitable cells. Nature Methods 3, 785-792 (2006).
14. Wang, H., et al. High-speed mapping of synaptic connectivity using photostimulation in Channelrhodopsin-2 transgenic mice. Proc. Natl Acad. Sci. USA 104, 8143-8148 (2007).
15. Arenkiel, B. R. et al. In vivo light-induced activation of neural circuitry in transgenic mice expressing channelrhodopsin-2. Neuron 54, 205-218 (2007).
16. Aravanis, A. M. et al. An optical neural inteface: in vivo control of rodent motor cortex with integrated fiberoptic and optogenetic technology. J. Neural Eng. 4, S143-S156 (2007).
17. Han, X. & Boyden, E. S. Multiple-color optical activation, silencing and desynchronization of neural activity with single-spike temporal resolution. PLoS ONE 2, e299 (2007).
18. Petreanu, L., Huber, D., Sobczyk, A. & Svoboda, K. Channelrhodopsin-2-assisted circuit mapping of longrange callosal projections. Nature Neurosci. 10, 663-668 (2007).
19. Li, X., et al. Fast noninvasive activation and inhibition of neural and network activity by vertebrate rhodopsin and green algae channelrhodopsin. Proc. Natl Acad. Sci. USA102, 17816-17821 (2005).
20. Nagel, G., et al. Light activation of channelrhodopsin-2 in excitable cells of Caenorhabditis elegans triggers rapid behavioral responses. Curr. Biol. 15, 2279-2284 (2005).
21. Ishizuka, T., Kakuda, M., Araki, R. & Yawo, H. Kinetic evaluation of photosensitivity in genetically engineered neurons expressing green algae light-gated channels. Neurosci. Res. 54, 85-94 (2006).
22. Schroll, C., et al. Light-induced activation of distinct modulatory neurons triggers appetitive or aversive learning in Drosophila larvae. Curr. Biol. 16, 1741-1747 (2006).
23. Nagel, G., et al. Channelrhodopsin-2, a directly lightgated cation-selective membrane channel. Proc. Natl Acad. Sci. USA 100, 13940-13945 (2003).
24. Soliman, G. S. H. & Truper, H. G. Halobacterium pharaonis: a new, extremely haloalkaliphilic archaebacterium with low magnesium requirement. Zentralblatt für Bakteriologie Mikrobiologie und Hygiene erste Abteilung Originale C, Allgemeine, angewandte und ökologische Mikrobiologie 3, 318-329 (1982).
25. Bi, A. et al. Ectopic expression of a microbial-type rhodopsin restores visual responses in mice with photoreceptor degeneration. Neuron 50, 23-33 (2006).
26. Lein, E. S. et al. Genome-wide atlas of gene expression in the adult mouse brain. Nature 445, 168-176 (2007).
27. Shimada, M., Tritos, N. A., Lowell, B. B., Flier, J. S. & Maratos-Flier, E. Mice lacking melanin-concentrating hormone are hypophagic and lean. Nature 396, 670-674 (1998).
28. Tecott, L. H. & Wehner, J. M. Mouse molecular genetic technologies: promise for psychiatric research. Arch. Gen. Psychiatry 58, 995-1004 (2001).
29. Miyoshi, G. & Fishell, G. Directing neuron-specific transgene expression in the mouse CNS. Curr. Opin Neurobiol. 16, 577-584 (2006).
30. Cetin, A., Komai, S., Eliava, M., Seeburg, P. H. & Osten, P. Stereotaxic gene delivery in the rodent brain. Nature Protoc. 1, 3166-3173 (2006).
31. Davidson, B. L. & Breakefield, X. O. Viral vectors for gene delivery to the nervous system. Nature Rev. Neurosci. 4, 353-364 (2003).
32. Kaplitt, M. G., et al. Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial. Lancet 369, 2097-2105 (2007).
33. de Boer, A. G. & Gaillard, P. J. Drug targeting to the brain. Annu. Rev. Pharmacol. Toxicol. 47, 323-355 (2007).
34. Chhatwal, J. P., Hammack, S. E., Jasnow, A. M., Rainnie, D. G. & Ressler, K. J. Identification of cell-type-specific promoters within the brain using lentiviral vectors. Gene Ther. 14, 575-583 (2007).
35. Osten, P., Grinevich, V. & Cetin, A. Viral vectors: a wide range of choices and high levels of service. Handb. Exp. Pharmacol., 177-202 (2007).
36. van den Pol, A. N., Acuna-Goycolea, C., Clark, K. R. & Ghosh, P. K. Physiological properties of hypothalamic MCH neurons identified with selective expression of reporter gene after recombinant virus infection. Neuron 42, 635-652 (2004).
37. Taymans, J. M., et al. Comparative analysis of adenoassociated viral vector serotypes 1, 2, 5, 7, and 8 in mouse brain. Hum. Gene Ther. 18, 195-206 (2007).
38. Wickersham, I. R., Finke, S., Conzelmann, K. K. & Callaway, E. M. Retrograde neuronal tracing with a deletion-mutant rabies virus. Nature Methods 4, 47-49 (2007).
39. Barth, A. L., Gerkin, R. C. & Dean, K. L. Alteration of neuronal firing properties after in vivo experience in a FosGFP transgenic mouse. J. Neurosci. 24, 6466-6475 (2004).
40. Wang, K. H., et al. In vivo two-photon imaging reveals a role of arc in enhancing orientation specificity in visual cortex. Cell 126, 389-402 (2006).
41. Wickersham, I. R., et al. Monosynaptic restriction of transsynaptic tracing from single, genetically targeted neurons. Neuron 53, 639-647 (2007).
42. Ferezou, I., Bolea, S. & Petersen, C. C. Visualizing the cortical representation of whisker touch: voltage-sensitive dye imaging in freely moving mice. Neuron 50, 617-629 (2006).
43. Piyawattanametha, W., et al. Fast-scanning two-photon fluorescence imaging based on a microelectromechanical systems two-dimensional scanning mirror. Opt. Lett. 31, 2018-2020 (2006).
44. Miesenbock, G. & Kevrekidis, I. G. Optical imaging and control of genetically designated neurons in functioning circuits. Annu. Rev. Neurosci. 28, 533-563 (2005).
45. 2+ indicators: using genetics and molecular design to understand complex physiology. J. Physiol. 578, 55-67 (2007).
46. Airan R. D. et al. High-speed imaging reveals neurophysiological links to behaviour in an animal model of depression. Science 5 July 2007 (doi: 10.1126/science.1144400).
47. Mayberg, H. S. et al. Deep brain stimulation for treatment-resistant depression. Neuron 45, 651-660 (2005).
48. Schlaepfer, T. E. et al. Deep brain stimulation to reward circuitry alleviates anhedonia in refractory major depression. Neuropsychopharmacology (2007).
49. Rauch, S. L. et al. A functional neuroimaging investigation of deep brain stimulation in patients with obsessive-compulsive disorder. J. Neurosurg. 104, 558-565 (2006).
50. Machado, A., Ogrin, M., Rosenow, J. M. & Henderson, J. M. A 12-month prospective study of gasserian ganglion stimulation for trigeminal neuropathic pain. Stereotact. Funct. Neurosurg. 85, 216-224 (2007).
51. Rasche, D., Ruppolt, M., Stippich, C., Unterberg, A. & Tronnier, V. M. Motor cortex stimulation for long-term relief of chronic neuropathic pain: a 10 year experience. Pain 121, 43-52 (2006).
52. Hausser, M. & Smith, S. L. Neuroscience: controlling neural circuits with light. Nature 446, 617-619 (2007).